Skip to content

Partnership Revision Femoral Stems

by Howmedica Corp.

510(k) K972893

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK972893 Date3 Nov 1997ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LZO
Device Class
Class II
Regulation
21 CFR Part 888.3353
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 26 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

Partnership Revision Femoral Stems are titanium femoral stems with titanium plasma spray coating, intended for use in primary and revision total hip arthroplasty. These stems are press-fit into the proximal femur and do not achieve biological ingrowth fixation.

The stems are used with Howmedica V40 femoral heads, unipolar/bipolar components, and acetabular components. The device received FDA 510(k) clearance with K972893 on November 3, 1997, and is classified under product code LZO.

Other devices from Howmedica Corp.

See all devices from Howmedica Corp. →

Questions

AI-generated answers, 26 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What are Partnership Revision Femoral Stems used for?

    Partnership Revision Femoral Stems are titanium implants designed for use in both primary and revision total hip arthroplasty procedures. They are press-fit into the proximal femur and do not achieve biological ingrowth fixation.

  • What components are compatible with these femoral stems?

    These stems are designed to be used with Howmedica V40 femoral heads, unipolar/bipolar components, and acetabular components to complete the total hip arthroplasty system.

  • What is the regulatory status of these implants?

    The device received FDA 510(k) clearance with K972893 on November 3, 1997, and is classified under product code LZO. It was determined to be substantially equivalent through the traditional clearance process.

  • What is the fixation mechanism of these stems?

    Partnership Revision Femoral Stems utilize a press-fit fixation method into the proximal femur. They do not achieve biological ingrowth fixation, relying instead on the mechanical press-fit stability.